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Abstract Various micro-organisms are able to use
sterols/steroids as carbon- and energy sources for
growth. 3-Ketosteroid 9a-hydroxylase (KSH), a two
component Rieske non-heme monooxygenase com-
prised of the oxygenase KshA and the reductase KshB,
is a key-enzyme in bacterial steroid degradation. It
initiates opening of the steroid polycyclic ring struc-
ture. The enzyme has industrial relevance in the
synthesis of pharmaceutical steroids. Deletion of KSH
activity in sterol degrading bacteria results in blockage
of steroid ring opening and is used to produce valuable
C19-steroids such as 4-androstene-3,17-dione and 1,4-
androstadiene-3,17-dione. Interestingly, KSH activity
is essential for the pathogenicity of Mycobacterium
tuberculosis. Detailed information about KSH thus is
of medical relevance, and KSH inhibitory compounds
may find application in combatting tuberculosis. In
recent years, the 3D structure of the KshA protein of
M. tuberculosis H37Rv has been elucidated and
various studies report biochemical characteristics
and possible physiological roles of KSH. The current
knowledge is reviewed here and forms a solid basis for
further studies on this highly interesting enzyme.
Future work may result in the construction of KSH
mutants capable of production of specific bioactive
steroids. Furthermore, KSH provides an promising
target for drugs against the pathogenic agent M.
tuberculosis.
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Introduction
Early observations that microbes are able to degrade
cholesterol were made by So¨hngen (1913). Since then,
a range of bacteria were found to be able to utilize
sterols (Arima et al. 1969; Nagasawa et al. 1969),
many of which are actinobacteria (e.g. Rhodococcus,
Mycobacterium) (Donova 2007; Fernandes et al.
2003; Malaviya and Gomes 2008 (reviews)). Various
enzyme steps in the bacterial sterol degradation
pathways remain to be characterized, but in recent
years knowledge on sterol degradation has greatly
increased. A cholesterol catabolism gene cluster was
identified in R. jostii RHA1 and a cholesterol degra-
dation pathway was predicted (Van der Geize et al.
2007) (Fig. 1). Cholesterol is a C27 sterol and
degradation of its side chain to a C22 intermediate
occurs by a process similar to b-oxidation of fatty
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acids, yielding propionic acid and acetic acid. The
subsequent formation of C19 steroids yields another
propionic acid (Sih et al. 1968). In M. tuberculosis,
metabolic labeling studies at carbon atom C26 showed
that the propionic acid released from the side chain is a
precursor in the production of phthiocerol dimycoce-
rosate (PDIM), a surface lipid (Ouellet et al. 2010).
The C19 central metabolite derived from cholesterol is
AD, containing the polycyclic ring structure. Steroid
ring degradation has been described in some detail for
the Gram-negative bacterium Comamonas testoste-
roni TA441 (Horinouchi et al. 2012) and for the
actinobacteria Rhodococcus equi (Nocardia restric-
tus) ATCC 14887 (Gibson et al. 1966; Sih et al. 1968),
R. jostii RHA1 and M. tuberculosis (Van der Geize
et al. 2007). Several enzymes have been characterized
from these organisms as well as from Rhodococcus
erythropolis SQ1 (e.g. Van der Geize et al. 2002),
Nocardia corralina (e.g. Itagaki et al. 1990) and R.
rhodochrous DSM43269 (e.g. Petrusma et al. 2009).
Metabolic labelling studies at carbon atom C4 of
cholesterol in M. tuberculosis revealed that this carbon
atom in the ring structure is converted to CO2,
suggesting the generation of energy via the
Fig. 1 a The basic polycyclic ring structure of sterols and
steroids with carbon atoms 1–17. b Proposed cholesterol
catabolism in Rhodococcus species and Mycobacterium tuber-
culosis (Adapted from Van der Geize et al. 2007). Dashed
arrows indicate multiple enzymatic steps. The depicted steroids
are 1 5-cholestene-3b-ol (cholesterol), 2 5-cholestene-26-oic
acid-3b-ol, 3 4-cholestene-3-one, 4 4-cholestene-26oic acid-3-
one, 5 4-cholestene-24oic acid-3-one, 6 3-oxo-23,24-bisnorch-
ola-4-ene-22-oic acid, 7 4-androstene-3,17-dione (AD), 8 1,
4-androstadiene-3,17-dione (ADD), 9 9a-hydroxy-4-andro-
stene-3,17-dione (9OHAD), 10 9a-hydroxy-1,4-androstadiene-
3,17-dione (ADD), 11 3-hydroxy-9,10-secoandrost-1,3,5(10)-
triene-9,17-dione (3-HSA), 12 3,4-dihydroxy-9,10-secoandrost-
1,3,5(10)-triene-9,17-dione (3,4-DHSA), 13 4,5–9,10-diseco-3-
hydroxy-5,9,17-trioxoandrosta-1(10),2-diene-4-oic acid (4,9-
DSHA), 14 9,17-dioxo-1,2,3,4,10,19-hexanorandrostan-5-oic
acid (DOHNAA), 15 2-hydroxyhexa-2,4-diene-oic acid
(HHD). The compound between brackets is chemically
unstable. Hsd 3b-hydroxy steroid dehydrogenase, Cyp 125
cytochrome P450 CYP125, KstD 3-ketosteroid dehydrogenase,
KSH 3-ketosteroid 9a-hydroxylase, HsaAB 3-hydroxy-9,
10-seconandrost-1,3,5(10)-triene-9,17-dione 4-hydroxylase,
HsaC 3,4-dihydroxy-9,10-secoandrost-1,3,5(10)-triene-9,17-
dione dioxygenase, HsaD 4,5–9,10-diseco-3-hydroxy-5,9,17-
trioxoandrosta-1(10),2-diene-4-oic acid hydrolase. The A, B,
C and D ring of the steroid polycyclic ring structure are
indicated in compound 1 (Petrusma 2011)
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tricarboxylic acid (TCA)-cycle (Pandey and Sassetti
2008). Opening of the steroid polycyclic ring structure
in these organisms occurs via the so called 9,10-seco
pathway. Recently, an alternative 2,3-seco pathway
was proposed for aerobic sterol degradation, which
does not use oxygenase enzymes for side chain
cleavage and for the steroid ring opening event. In
the latter case, cleavage of the steroid polycyclic ring
structure starts with a hydrolytic attack on the A-ring.
The proposed pathway is based on identification of
cholesterol degradation intermediates in the gram
negative bacterium Sterolibacterium denitrificans
(Wang et al. 2013).
In actinobacteria, employing the 9,10-seco path-
way, the steroid B-ring is opened by dehydrogenation
of the steroid A-ring and by C9a-hydroxylation. The
sequence of these reactions is not known. The
dehydrogenation step is performed by 3-ketosteroid
dehydrogenase enzymes (KSTD) (Itagaki et al. 1990;
Knol et al. 2008; Van der Geize et al. 2000), whereas
3-ketosteroid 9a-hydroxylase enzymes (KSH) incor-
porate a hydroxyl moiety at C9 (Van der Geize et al.
2002). The resulting steroid structure, 9a-hydroxy-
1,4-androstadiene-3,17-dione (9OHADD), is chemi-
cally unstable and spontaneously hydrolyzes to the
phenol 3-hydroxy-9,10-secoandrost-1,3,5(10)-triene-
9,17-dione (3-HSA). 3-HSA is further degraded by the
HsaABCD enzymes. This involves C4-hydroxylation
by the flavin-dependent monooxygenase HsaAB (Dre-
sen et al. 2010), cleavage of the A-ring by the extradiol
dioxygenase HsaC (Yam et al. 2009) and hydrolysis
by HsaD (Lack et al. 2010) yielding 9,17-dioxo-
1,2,3,4,10,19-hexanorandrostan-5-oic acid (DO-
HNAA) and 2-hydroxyhexa-2,4-diene-oic acid
(HHD). The fate of the DOHNAA product is not
entirely clear yet. HHD is further degraded to propi-
onic acid and pyruvate. The two main events in
microbial sterol catabolism are C17-side chain degra-
dation and opening of the polycyclic ring structure.
The sequence of these events may differ between
organisms. R. jostii RHA1 is thought to first attack the
sterol side chain followed by opening of the steroid
ring structure (Rosłoniec et al. 2009). In M. tubercu-
losis H37Rv both events may occur simultaneously,
since its KSH displays high substrate preference for a
CoA thioester intermediate of cholesterol side chain
degradation (Capyk et al. 2011). In bile acid transfor-
mations with three Rhodococcus strains, 9,10-seco-
steroid intermediates with partially degraded C17 side
chains were detected, suggesting that C17-side chain
degradation and opening of the steroid polycyclic ring
structure occur simultaneously (Costa et al. 2013a, b).
Although microbial steroid hydroxylation is well
documented, starting with the discovery of progester-
one 11a-hydroxylation by a Rhizopus species in 1952
(Peterson and Murray 1952), the responsible enzymes
are in most cases not known. Over the years, several
cytochrome P450 (CYP) enzymes were found to be
involved in steroid hydroxylation (Donova and Egor-
ova 2012 (review); Fernandes et al. 2003 (review);
Holland 1999 (review); Rosłoniec et al. 2009).
Examples of microbial steroid hydroxylation medi-
ated by P450 enzymes are 11a-hydroxylation by
Rhizopus nigricans (Breskvar et al. 1991), 11b-
hydroxylation by Curvularia lunata (Suzuki et al.
1993) and 14a-hydroxylation by Mucor piriformis
(Madyastha and Joseph 1993) and the 26/27-hydrox-
ylases CYP125 of Rhodococcus jostii RHA1
(Rosłoniec et al. 2009) and CYP142 of Mycobacte-
rium tuberculosis (Driscoll et al. 2010).
Various steroid hydroxylases play a role in micro-
bial steroid degradation, resulting in hydroxylation of
steroids at virtually every carbon atom (Fernandes
et al. 2003; Mahato and Garai 1997; Donova 2007;
Donova and Egorova 2012 (reviews)). Pharmaceutical
steroids have a wide range of applications and
hydroxylated steroids, often displaying high bioactiv-
ity, are of large industrial and medical relevance. The
pharmaceutically most interesting sites for hydroxyl-
ation are at carbon atoms C-7a, C-9a, C-11a, C-11b,
C-16a, C-17a (Donova and Egorova 2012 (review)).
Steroid C9-hydroxylation and C11-hydroxylation
reactions for instance are important for the production
of corticosteroids (Kano et al. 1979; Megges et al.
1990).
Steroid C9a-hydroxylation is catalyzed by the
3-ketosteroid 9a-hydroxylase (KSH) enzyme. KSH
is a key-enzyme in bacterial steroid degradation and
initiates opening of the steroid polycyclic ring struc-
ture. The two-component Rieske-type non-heme
monooxygenase KSH consists of the terminal oxy-
genase KshA and the ferredoxin reductase KshB.
Deletion of KshA activity in sterol degrading bacteria
results in blockage of steroid ring opening and is used
to produce valuable C19-steroids, such as 4-andro-
stene-3,17-dione (AD) and 1,4-androstadiene-3,17-
dione (ADD), core metabolites in the sterol degrada-
tion pathway (Andor et al. 2006; Van der Geize et al.
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2002; Wilbrink et al. 2011). These steroids can be used
as precursors for virtually all pharmaceutically inter-
esting steroids (Wang et al. 2011 (review)). Interest-
ingly, it has been reported that KSH is essential for the
pathogenicity of M. tuberculosis (Hu et al. 2010).
Insight into this important enzyme can provide new
leads for the development of inhibitors to be used as
drugs against this notorious pathogen.
3-Ketosteroid 9a hydroxylase, a multimeric two
component Rieske type non-heme oxygenase
KSH is a key enzyme in bacterial sterol degradation,
initiating the opening of the steroid polycyclic ring
structure by C9a-hydroxylation (Gibson et al. 1966;
Van der Geize et al. 2002). Characterization of
enzymes involved in C9a-hydroxylation of steroids
started with a partly purified NADH dependent three
component enzyme system of Nocardia sp. M117
(Strijewski 1982). The enzymes were identified as a
flavoprotein reductase and two iron–sulphur proteins.
Genes encoding a two component KSH enzyme
system were first identified in R. erythropolis SQ1
(Van der Geize et al. 2002). UV-mutagenesis of R.
erythropolis SQ1 and screening and characterization
of mutants impaired in growth on AD but still able to
grow on 9a-hydroxyAD (9OHAD) revealed that the
kshA and kshB genes are involved in steroid C9a-
hydroxylation. Unmarked gene deletion in R. ery-
thropolis SQ1 (van der Geize et al. 2001) of either
kshA or kshB both resulted in mutant strains incapable
of growth on AD. Based on its amino acid sequence,
KSH was identified as a Rieske non-heme monoox-
ygenase enzyme system. Monooxygenases are also
called mixed-function oxygenases because they incor-
porate one oxygen atom into the substrate and one
atom is reduced to H2O (Harayama et al. 1992; Mason
and Cammack 1992 (reviews)).
Rieske non-heme oxygenases (ROs) constitute a
distinct class of enzymes. They are found in a wide
range of organisms but occur most abundantly in
bacteria. The members of this enzyme family are
involved in catabolism of a wide range of substrates,
including many aromatic and toxic compounds (Cha-
kraborty et al. 2012). Therefore, these enzymes are of
great environmental and industrial importance. ROs
are multicomponent redox enzyme systems,
consisting of an oxygenase and one or two reducing
enzymes. The oxygenase component, which performs
the substrate hydroxylation, is an iron–sulphur protein
and contains a non-heme iron situated at the active
site. KSH enzymes employ an electron transport chain
that starts with the oxidation of NADH. The electrons
are transferred to the flavin co-factor (FAD) of the
ferredoxin reductase component KshB and then
transported to the plant type iron–sulphur cluster of
KshB. The Rieske iron–sulphur cluster of the KshA
oxygenase component subsequently accepts the elec-
trons from KshB. The electrons end up at the non-
heme iron situated in the active site of KshA. The
mononuclear iron is the site where O2 is bound and
activated and the substrate is hydroxylated (Batie et al.
1991; Mason and Cammack 1992 (review)) (Fig. 2).
The crystal structure of KshA of M. tuberculosis
revealed that the Rieske iron–sulphur cluster and the
non-heme Fe2? catalytic centre are located relatively
far away from each other. Crystal structures from other
ROs confirm that this is characteristic for this type of
protein. However, the typical head-to-tail trimer
arrangement positions the Rieske Fe2S2 in close
proximity to the non-heme Fe2? of the neighbouring
KshA subunit, enabling transport of electrons between
KshA subunits (Fig. 3). A conserved aspartic acid,
Asp178 of KshA of M. tuberculosis (Capyk et al.
2009), plays a key role in this arrangement by
formation of hydrogen bonds, thereby facilitating
electron transfer between adjacent subunits (Parales
et al. 1999). This aspartate has also been implicated in
catalysis (Beharry et al. 2003; Pinto et al. 2006;
Tarasev et al. 2006). A common feature of non-heme
iron enzymes is the 2-His-1-carboxylate facial triad
motif binding the non-heme iron in the core of the
active site. The iron is thus coordinated in the protein
by three endogenous ligands leaving it largely exposed
and creating a very reactive active site (Fig. 2). Up to
three exogenous ligands can be bound to the metal
centre (Bruijnincx et al. 2008; Hegg and Que 1997
(reviews)). The metal centre of KshA is coordinated at
the core of the active site by two histidines (His181
and His186) and an aspartate (Asp304) residue (Capyk
et al. 2009). As in several Rieske oxygenases, the iron
is bidentate bound to the carboxyl group of the
aspartate leaving two sites available for exogenous
ligands. This metal centre is more labile compared to
the covalently bound heme–iron. However, non-heme
iron is a highly catalytic platform able to bind O2 and
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steroid substrate simultaneously in different
orientations.
Rieske oxygenases are known to catalyze a range of
chemical reactions such as dioxygenation and mo-
nooxygenation. Several ROs are known to perform
both reactions, e.g. carbazole 1,9a-dioxygenase (Noj-
iri et al. 1999). Furthermore, ROs are also known to
catalyze reactions like desaturation (e.g. Torok et al.
1995), O-dealkylation (Resnick and Gibson 1993),
sulfoxidation (Boyd et al. 2004; Lee et al. 1995),
desulphonative dioxygenation (Locher et al. 1991) and
oxidative carbocyclization (Sydor et al. 2011). This
range of reactions performed by ROs demonstrates the
large catalytic capacity of the non-heme iron active
site. The reaction mechanism of KSH is unknown and
although many studies provide insight into the nature
of catalysis of ROs, the precise catalytic mechanism of
ROs is still unclear. However, some common mech-
anistic features are apparent for ROs. The first step in
catalysis is binding of the substrate in the active site
and reduction of the non-heme iron (Fe2?). Further-
more, the Rieske iron–sulphur cluster also needs to be
in a reduced state. Only when the oxygenase is in this
state, O2 can bind to the metal centre. This arrange-
ment prevents uncoupling because all components of
the reaction are necessary for activation of O2 (Barry
and Challis 2013; Neidig and Solomon 2005
(reviews)). Crystal structures of naphthalene dioxy-
genase provided evidence for side-on (g2) binding of
O2 to the metal centre, meaning that both O-atoms are
bound to the Fe2?. This type of O2 binding may
explain the high regiospecificity observed for many
ROs. This contrasts with CYP enzymes, which bind
O2 in an end-on fashion, meaning that only one oxygen
atom is bound to the heme iron (Karlsson et al. 2003).
The versatility and high regiospecificity of ROs makes
the enzymes very interesting for industrial
applications.
Fig. 2 Electron transport chain reactions and substrate hydrox-
ylation catalyzed by KSH. Arrows indicate the flow of electrons,
starting from the electron donor NADH to the flavin co-factor of
KshB, FAD, and via the plant type iron–sulphur cluster,
coordinated by four cysteines, of KshB to the Rieske iron–
sulphur cluster, coordinated by two cysteines and two histidines,
of KshA ending up at the non-heme iron at the core of the
catalytic domain. Non-heme iron is coordinated by an aspartate
and two histidine residues leaving two binding sites open. Here
O2 can be bound and one O-atom is used for the hydroxylation of
the steroid substrate while the other O-atom is reduced to H2O
(Petrusma 2011)
Fig. 3 Schematic representation of the typical head-to-tail
trimer arrangement of KshA enzymes (adapted from Capyk
et al. 2009). Three KshA units are shown in light grey, dark grey
and black, forming a circle. Also the FAD co-factor and the
iron–sulphur cluster of KshB are depicted. Electrons (e-) are
transferred from the iron–sulphur cluster of KshA to the non-
heme Fe2? of the neighbouring KshA unit. AD and 9OHAD
indicate 4-androstene-3,17-dione and 9a-hydroxy-4-andro-
stene-3,17-dione, respectively (Petrusma 2011)
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The oxygenase component of ROs is either an a-
subunit alone, e.g. KshA, the oxygenase component of
KSH, or contains both an a-subunit and a b-subunit
(Mason and Cammack 1992 (review)). The b-subunit
is smaller and its function has not been elucidated.
Several studies indicate a role for the b-subunit in
substrate hydroxylation activity (e.g. Jiang et al.
1999). However, other studies indicate that the b-
subunit has a structural role and is not involved in
substrate specificity or selectivity (e.g. Friemann et al.
2005). 3D structures are available for a range of
Rieske non-heme oxygenases. All enzymes are
organized in either an a3 trimer, e.g. KshA (Capyk
et al. 2009) (Fig. 3) or an a3b3 hexamer, e.g.
nitrobenzene dioxygenase (Friemann et al. 2005). An
exception is the phthalate dioxygenase of Burkholde-
ria cepacia (DB01) which is organized as an a3a3
stacked hexamer (Tarasev et al. 2007). The a-subunit,
e.g. KshA, contains a Rieske domain, coordinating the
Rieske Fe2S2 cluster, and a catalytic domain with the
typical helix-Grip fold, which is part of the StAR
(steroidogenic acute regulatory protein) related lipid
transfer (START) domain superfamily. The catalytic
domain is composed of a b-sheet flanked by a-helices
(Iyer et al. 2001). The oxygenase component of ROs is
reduced by a ferredoxin reductase, e.g. KshB in KSH.
In three component systems the electrons are shuttled
between the oxygenase and the reductase by a small
ferredoxin (Mason and Cammack 1992(review)). This
ferredoxin has not been detected for KSH.
Amino acid sequence analysis of KshA (oxygen-
ase) reveals a Rieske iron–sulphur binding motif and a
non-heme Fe2? binding motif, and KshB (reductase)
has a flavin, NADH and plant type iron–sulphur
binding motifs (Van der Geize et al. 2002) (Fig. 4).
KSH was thus classified als a class IA RO enzyme
system according to the RO classification system
proposed by Batie et al. (1991) (Table 1). This
classification is based on the diversity of electron
transport components in the oxygenases. The terminal
oxygenase is dependent on a ferredoxin reductase for
reduction. Several RO systems need a third protein, a
small ferredoxin that shuttles electrons between the
ferredoxin reductase and the terminal oxygenase.
Location, number and nature of the iron–sulphur
clusters are used as characteristics to group oxygen-
ases. The Batie classification system consists of three
main classes, of which class I and class II are
subdivided in group A and B. Class I oxygenases
consist of two components, a terminal oxygenase and a
ferredoxin reductase. Class IA ferredoxin reductases
have N-terminal FMN as co-factor while FAD is co-
factor in class IB, located between the iron–sulphur
binding domain and the NAD binding domain (Correll
et al. 1992). Class II and III oxygenases employ
ferredoxin as a third component. In class II systems the
ferredoxin reductase contains FAD and the ferredoxin
an iron–sulphur cluster. Class II is subdivided in group
A and B on the basis of the nature of the iron–sulphur
cluster of the ferredoxin. In class III the ferredoxin
reductase contains both a FAD and an iron–sulphur
cluster. The reductase component of class III shows
strong similarity to the reductase of class IB. However,
in the class III systems a ferredoxin, containing an
iron–sulphur cluster is required for electron transfer
between the reductase and the oxygenase (Batie et al.
1991).
The Batie classification system for ROs has been
broadly applied. The biochemical classification has a
strong evolutionary basis (Harayama et al. 1992
(review); Nakatsu et al. 1995; Neidle et al. 1991).
However with the identification of a growing number
of ROs, more and more enzymes are found to have
characteristics that do not fit the Batie classification
system. KSH was also initially classified as a Class IA
RO based on amino acid sequence analysis. However,
biochemical characterization of KshB showed the
presence of FAD as co-factor indicative for a class IB
oxygenase (Capyk et al. 2009; Petrusma et al. 2009).
A new classification system was introduced by
Nam et al. (2001) based on the amino acid sequence of
the oxygenase components (the alpha subunits).
Evolutionary relationships among oxygenases do not
appear to be related to substrate specificity, since
oxygenases sharing similar substrate ranges can be
classified in different groups, based on amino acid
sequence similarity. The Nam-system consists of four
groups. KSH was classified as a group I RO in this
classification system. Group I contains a broad range
of mono- and dioxygenases with low amino acid
sequence similarity and various protein sizes. The
oxygenases are a-monomers. Sequence alignments
did not allow elucidation of the specific domains
necessary for monooxygenation or dioxygenation
specificity. Characteristic for group I oxygenases are
16 or 18 residues between the first histidine residue
and the second cysteine residue of the Rieske iron–
sulphur binding domain. In contrast, oxygenases of
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group II, III and IV all have 17 residues separating the
first histidine and second cysteine. The two histidines
binding the non-heme Fe2? are separated by 3 or 4
amino acids in class I, 4 amino acids in class II and III
and 4 or 5 amino acids in class IV. The system
proposed by Nam et al. (2001) also allows classifica-
tion according to the electron transport chain. Group II
oxygenases are composed of two components, groups
III and IV are made up of three components and group
I has either 2 or 3 components. The Batie et al. (1991)
and Nam et al. (2001) classification systems are based
on the composition of the electron transport chain of
oxygenases and on the amino acid sequences of the
oxygenases, respectively. Together, they complement
each other and give more insight into similarities and
differences of ROs. In 2008, another classification
system was introduced by Kweon et al. (2008) that
incorporated both information about the composition
of the electron transport chain as well as the oxygenase
component. This classification system is based on
information of all components of ROs but is also
reliable in classifying incomplete oxygenases systems.
Thus, this classification system can predict the
presence of unknown electron transport components.
The classification consists of five types of oxygenases.
KshA was classified as a Type I oxygenase in the
Kweon et al. (2008) classification system. A modifi-
cation of the Kweon classification was suggested by
Fig. 4 Co-factor binding amino acid sequence motifs in KshA
and KshB of R erythropolis SQ1 (R. ery) (KshA1, KshB (Van
der Geize et al. 2002); KshA2 (Van der Geize et al. 2008), R.
jostii RHA1 (Ro gene numbering) (Mathieu et al. 2010; Van der
Geize et al. 2007). M. smegmatis mc2155 (MSMEG_5925)
(Andor et al. 2006; Arnell et al. 2007), M. tuberculosis (RV)
(Capyk et al. 2009) and R. rhodochrous DSM43269 (R. rho)
(Wilbrink et al. 2011). * indicates conserved residues. (Petrusma
2011)









IA 2 FMN [Fe2S2Cys4] – [Fe2S2Cys2His2] non-heme Fe
2?
IB 2 FAD [Fe2S2Cys4] – [Fe2S2Cys2His2] non-heme Fe
2?
IIA 3 FAD [Fe2S2Cys4] [Fe2S2Cys2His2] non-heme Fe
2?
IIB 3 FAD [Fe2S2Cys2His2] [Fe2S2Cys2His2] non-heme Fe
2?
III 3 FAD [Fe2S2Cys4] [Fe2S2Cys2His2] [Fe2S2Cys2His2] non-heme Fe
2?
Antonie van Leeuwenhoek (2014) 106:157–172 163
123
Chakraborty et al. 2012. This modification includes
combinations of electron transport chain components
based on evolutionary relationships between the
different RO components as well as functional prop-
erties of the ROs. Oxygenase components of ROs
share structural similarities but are very diverse in
amino acid sequence. A phylogenetic study, combin-
ing structural information and amino acid sequences
of the oxygenase components of ROs, suggest that
classification of ROs in such broad groups is not
feasible (Capyk and Eltis 2012). The RO phylogenetic
tree shows two distinct groups but within these groups
specific clans cannot be identified. One exception is a
large clan in group II, also containing KshA of M.
tuberculosis H37Rv. Interestingly, KshA is clustered
with the eukaryotic Neverland enzyme, a cholesterol
7,8-dehydrogenase. The authors propose a new clas-
sification system which is constituted of smaller
groups, with functional similarities between the
members of such a group. This system would be
similar to the naming system of P450s. Since this new
classification system is focussed on the oxygenase
component of ROs, the system introduced by Batie
et al. 1991 would complement the new system because
it also includes the other components of the electron
transport chain of ROs (Capyk and Eltis 2012).
After the identification of KSH in R. erythropolis
SQ1 (van der Geize et al. 2001) a kshA gene was also
identified in Mycobacterium smegmatis mc2 155.
E. coli cells expressing this KshA displayed C9a-
hydroxylating activity on AD and progesterone. Upon
purification of the enzyme the hydroxylating activity
was greatly reduced (Andor et al. 2006; Arnell et al.
2007). kshA and kshB of R. rhodochrous DSM43269
were co-expressed in E. coli and whole cell biocon-
version of AD to 9OHAD was observed, with a yield of
[60 % after 48 h (Petrusma et al. 2009). KshA and
KshB of both R. rhodochrous DSM43269 (Petrusma
et al. 2009) and M. tuberculosis (Capyk et al. 2009)
has been purified in active forms and were dependent
on NADH as electron donor for activity. KshA of M.
tuberculosis was purified anaerobically (Capyk et al.
2009) while KshA of R. rhodochrous DSM43269 was
purified aerobically but only remained in an active
form when purified together with KshB, resulting in an
active KSH enzyme (Petrusma et al. 2009). The 3D
structure of KshA of M. tuberculosis has been
elucidated (Capyk et al. 2009). It contains a Rieske
iron–sulphur cluster and a divalent non-heme iron
located in the core of the active site. KshA subunits are
organized in trimers, forming a typical a3-fold as
mentioned above (Fig. 3). The catalytic domain of
KshA is organized in the typical Helix–Grip fold (see
above) but differs from other known a3-ROs in the
shape of the substrate-binding pocket and position of
active site channel, equipped for steroid substrates.
KshA has distinct C-terminal features involved in
formation of the a-trimer. It was suggested that KshA
is an archetypical RO because the structure shows a
minimal catalytic domain compared to other available
RO structures (Capyk et al. 2009) (Fig. 5). In vitro
bioassays with KSHs of M. tuberculosis H37Rv and R.
rhodochrous DSM43269 showed that the enzymes can
use 3-ketosteroids as substrates. They can tolerate
different configurations of the A-ring and some
enzymes display hydroxylation activity on steroids
with longer C17 side chains. As mentioned above,
KSH of M. tuberculosis shows high preference for the
CoA thioester intermediate of cholesterol side chain
degradation compared to the tested C17-ketosteroids.
These studies indicate that KSH activity can occur at
different stages of the sterol degradation pathway
(Capyk et al. 2011; Petrusma et al. 2011).
Physiological roles of KSH enzymes
Sterols and steroids can be degraded by a range of
microorganisms, many of which are actinobacteria,
e.g. Rhodococcus and Mycobacterium species, and
serve as carbon- and energy sources for growth
(Donova 2007; Fernandes et al. 2003; Malaviya and
Gomes 2008; Van der Geize and Dijkhuizen 2004
(reviews)). KSH is a key enzyme in bacterial sterol
catabolic pathways. The essential role of KSH in
opening of the steroids polycyclic ring structure was
demonstrated for the first time in R. erythropolis SQ1.
The kshA and kshB gene deletion mutants were able to
grow on 9-OHAD but not on AD. This strain,
however, was still able to grow on phytosterols,
indicating the presence of additional KshA enzymes or
an alternative degradation pathway (Van der Geize
et al. 2002). A kshA disruption mutant of Mycobac-
terium smegmatis mc2 155 incubated with sitosterol
accumulated AD and ADD (Andor et al. 2006). R.
rhodochrous DSM43269 expresses 5 KshA homologs.
A kshA null mutant was constructed by gene deletion
mutagenesis (strain RG32) to fully block opening of
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the steroids polycyclic ring structure of cholesterol
and b-sitosterol; this resulted in accumulation of ADD
and 3-oxo-23,24-bisnorchola-1,4-dien-22-oic acid
(1,4-BNC) (Wilbrink et al. 2011). These mutants still
degraded the sterol side chain, thus demonstrating the
potential of mutant bacterial strains to convert rela-
tively cheap sterol substrates into valuable steroids.
Rhodococci were found to have relatively large
genomes, displaying strong gene diversity. Multiple
copies are present for many genes, encoding (iso)-
enzymes for specific steps in catabolic pathways. Such
a multiplicity was also observed for kshA. The genome
of R. erythropolis SQ1 harbours at least 3 kshA genes
(Van der Geize et al. 2008). R. jostii RHA1 encodes
four sterol catabolic gene clusters, each of which
contains a kshA gene, namely ro04538 (kshA),
ro02490 (kshA2), ro05811 (kshA3) and ro09003
(kshA4) (Mathieu et al. 2010; McLeod et al. 2006;
Van der Geize et al. 2007). A total of five kshA
homologues were identified in R. rhodochrous
DSM43269 (Wilbrink et al. 2011) and Mycobacterium
sp. VKM Ac-1817D (Bragin et al. 2013), and seven
kshA homologues are present in the genome of the
pathogenic bacterium R. equi. Multiplicity for kshB is
not as excessive as for kshA. Apparently, KshB is able
to serve as a reductase for several KshA enzymes. In
Fig. 5 Crystal structure of
KshA of M. tuberculosis
H37Rv (a), with non-heme
iron coordinating residues in
orange (His181, His186 and
Asp304) and putative
substrate interacting




Capyk et al. 2009, PDB:
2ZYL). Stereo image of an
ADD docking experiment
indicating substrate
interacting residues of KshA
(b) (This figure was
originally published in
Journal of Biological
Chemistry. Capyk et al.
(2009) 284:9937–9946 
the American Society for
Biochemistry and Molecular
Biology.)
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vitro bioassays of the five KshA homologues of R.
rhodochrous DSM43269 also shows that all KshAs are
able to use the same KshB as reductase (Petrusma et al.
2011). Little is known about the physiological roles of
the different KshA homologues. In vivo, each of these
KshA homologues may have a specific role in the host
bacterium, degrading certain sterol/steroid substrates.
Sterol catabolic gene cluster 1 of R. jostii RHA1 was
designated as a cholesterol degradation gene cluster.
Most genes within this cluster are upregulated during
growth on cholesterol, including kshA (ro04538). The
study showed that several pathogenic bacteria also
harbour a cholesterol degradation cluster and in
Mycobacterium bovis bacillus Calmette–Gue´rin kshA
was found to be upregulated during growth on
cholesterol. A cholesterol catabolic gene cluster was
also identified in M. tuberculosis (Van der Geize et al.
2007).
R. jostii RHA1 gene expression has been analyzed
during growth on 7-ketocholesterol (7-KC) and
revealed that a set of genes, among which kshA3,
was specifically upregulated during growth on 7-KC
compared to cholesterol. However, many genes were
upregulated on both sterols suggesting a common
degradation pathway (Mathieu et al. 2010). Promoter
activity experiments with kshA2 of R. erythropolis
SQ1 showed that kshA2 is highly induced by 9a-
hydroxy-4-androstene-3,17-dione (9-OHAD), a KSH
product. It was speculated that this kshA homologue
prevents accumulation of ADD to toxic levels during
sterol catabolism (Van der Geize et al. 2008). Molec-
ular studies with the five KshA homologues of R.
rhodochrous DSM43269 indicated that these isoen-
zymes are involved in degradation of specific types of
sterols and/or at different levels in the degradation
cascade. KshA1 of R. rhodochrous DSM43269
appears to be dedicated to cholate catabolism. Expres-
sion of kshA1 was induced during growth on cholic
acid. Furthermore, the growth of a R. rhodochrous
DSM43269 kshA null mutant, unable to grow on
cholate, was restored to wild type level by comple-
mentation by KshA1, and the KshA1 enzyme also
showed substrate preference for an intermediate in
cholate catabolism (Petrusma et al. 2011). KshA1 of R.
rhodochrous and KshA3 of R. jostii RHA1 are
clustered in the same group in a KshA phylogenetic
tree (Fig. 6). Phylogenetic analysis showed clustering
of KshA enzymes in different groups. It was hypoth-
esized that the members of such a group are
functionally related, involved in catabolism of specific
steroids (Petrusma et al. 2011). The gene cluster of R.
jostii RHA1 harboring kshA3 (ro05811) was found to
be essential for cholate catabolism. Many genes in the
cluster, among which kshA3, were found to be highly
upregulated during growth on cholate compared to
cholesterol. Several bacteria harbouring orthologous
gene clusters in their genomes were also found to be
able to grow on cholate while all tested bacteria
lacking such a gene cluster were unable to grow on this
bile acid. A kshA3 deletion mutant confirmed that the
KshA3 enzyme is essential for growth on cholate
(Mohn et al. 2012).
KSH is essential for the pathogenicity
of M. tuberculosis
M. tuberculosis has a much smaller genome than most
Rhodococcus species characterized and does not
display the high gene multiplicity characteristic for
most rhodococci. Indeed, the genome of M. tubercu-
losis harbours one kshA gene and one kshB gene. M.
tuberculosis is one of the most notorious human
pathogenic bacteria. Each year approximately 1.5
million deaths are caused by the disease tuberculosis
and millions of people are infected (www.who.int/tb/
country/en/index.html). M. tuberculosis is such a
successful pathogen because it is able to survive for
long periods of time (chronic) within macrophages in
the lungs (Meena and Rajni 2010 (review)). In recent
years it was found that cholesterol catabolism plays an
important role in the survival of M. tuberculosis in
macrophages (Rengarajan et al. 2005; Sassetti and
Rubin 2003; Schnappinger et al. 2003; Van der Geize
et al. 2007). The precise role of cholesterol degrada-
tion in M. tuberculosis however is not clear. Several
enzymes were found to be essential for survival of M.
tuberculosis during infection (see below), but cho-
lesterol does not serve as the sole energy source during
infection (Yang et al. 2011). It has been suggested that
steroid intermediates of the bacterial cholesterol deg-
radation pathway modulate the immune response of
the human host (Klink et al. 2013; Yam et al. 2011
(review)).
Several studies have shown that cholesterol catab-
olism in M. tuberculosis is essential in the chronic
phase of infection and in IFN-c-activated macro-
phages but not during the onset of infection or in
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resting macrophages (Nesbitt et al. 2010; Pandey and
Sassetti 2008). However, transposon mutagenesis
studies (Rengarajan et al. 2005; Sassetti and Rubin
2003) and targeted gene inactivation studies of genes
coding for enzymes involved in steroid ring degrada-
tion (Hu et al. 2010; Yam et al. 2009), indicated that
sterol catabolism is essential in the early stages of
infection as well as in the chronic phase. Both KSH
components were found to be essential for pathogen-
esis. The separate kshA and kshB deletion mutants
were unable to survive in mice models, and in
macrophages, in the early stage of infection as well
as in the chronic phase. These mutant strains, unlike
wild type M. tuberculosis, were unable to catabolize
cholesterol, AD and 5a-androstane-3,17-dione (5a-
AD). The kshB deletion mutant was also impaired in
biosynthesis of penta-acylated trehalose (PAT), a
glycolipid located at the surface of the cell wall. The
data suggests that KshB can serve as a reductase for
different oxygenases (Hu et al. 2010).
Fig. 6 Phylogenetic tree of
bacterial KshA enzymes
(Petrusma et al. 2011)
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Engineering of Rieske non-heme oxygenase
enzymes
The essential role of KSH in the pathogenicity of M.
tuberculosis as well as its potential in production of
pharmaceutically interesting steroids make these
enzymes an interesting target for protein engineering.
One of the best studied ROs is biphenyl dioxygenase.
Mutational engineering of this class III oxygenase
(Batie et al. 1991) has resulted in enhanced activities,
changed and/or expanded substrate ranges and
altered regio selectivity (Furukawa et al. 2004
(review)). This susceptibility for enzyme engineering
of biphenyl dioxygenase is in agreement with the
finding that enzyme homologues from a Burkholde-
ria strain and a Pseudomonas strain only differ by 20
amino acids, of a total of * 460 amino acid
residues, while showing clear differences in func-
tionality. Indeed, recombination of the genes encod-
ing these highly similar enzymes by DNA shuffling
resulted in altered substrate ranges and enhanced
activities (Kumamaru et al. 1998). Intriguingly, the 5
KshA homologues of R. rhodochrous DSM43269
(Petrusma et al. 2011), as well as the KshA of M.
tuberculosis (Capyk et al. 2009), all perform C9a-
hydroxylation of steroid molecules while sharing
*60 % amino acid identity. However, all amino acid
residues predicted to interact with the polycyclic ring
structure of the substrate bound in the active site
(Fig. 5) are conserved among known KshAs (Capyk
et al. 2009). The KshADSM43269 homologues were all
found to act on 3-ketosteroids showing overlap in
substrate ranges, but with differences in substrate
preference (Petrusma et al. 2011).
Naphthalene 1,2-dioxygenase of Pseudomonas sp.
strain NCIB 9816-4 also has been well studied and
subjected to several mutagenesis studies. This RO
uses a large range ([ 60) of aromatic compounds as
substrates and performs different types of reactions,
i.e. di- and monooxygenation, desaturation, sulphox-
idation. The suitability of this RO for enzyme
engineering was demonstrated by the fact that
several point mutations around the active site
affected substrate specificity as well as regio- and
enantioselectivity (Ferraro et al. 2006; Parales 2003
(review)). The amino acid sequence identity
between KshA, biphenyl dioxygenase and naphtha-
lene 1,2-dioxygenase however is very low. Carba-
zole 1,9a-dioxygenase (CARDO, Janthinobacterium
sp. strain J3) shares about 18 % amino acid
sequence identity with KshAs of both R. rhodoch-
rous DSM43269 and M. tuberculosis and this RO is
classified as a class III oxygenase on the basis of the
electron transport chain enzymes (Nojiri et al.
2005). Point mutations of residues lining the
substrate binding pocket resulted in CARDO
mutants displaying changes in substrate specificity.
Most of these mutated residues are situated near the
active site. However, mutation of a residue near the
entrance of the substrate binding pocket, close to a
loop situated at the entrance of the substrate binding
pocket, was found to improve activity on specific
substrates (Uchimura et al. 2008). Similar loop
regions are situated at the entrance of the substrate
binding domain of many ROs. It has been specu-
lated that this feature is involved in accommodation
of substrates in the active site (Ferraro et al. 2005
(review)). Indeed, a study on chimeric KshA
enzymes of R. rhodochrous DSM43269, with
exchange of regions of the catalytic domain of
two KshA homologues with different substrate
preferences showed that the loop region, located at
the entrance of the active site, strongly influences
substrate specificity (Petrusma et al. 2012). A
docking experiment with KshA of M. tuberculosis
and 3-oxo-23,24-bisnorchola-1,4-dien-22-oyl-coen-
zyme A thioester (1,4-BNC-CoA) as substrate
indicated the importance of amino acid residues in
a pocket located at the entrance of the active site,
which is the predicted location of the CoA group of
this preferred substrate. In contrast to the amino acid
residue at the active site that interacts with the
polycyclic ring structure of ADD (Capyk et al.
2009), the residues near the entrance of the active
site interacting with the CoA group are not
conserved among known KshAs, indicative for
differences in substrate range and specificity of the
different KshAs (Capyk et al. 2011).
Detailed insights into the structure and function
relationships of KshA, and the amino acid residues
involved in substrate range and specificity, as well as
regioselectivity of the hydroxylation, will provide a
firm basis for subsequent rational engineering of KshA
enzymes to improve synthesis of desired bioactive
steroids. Also, since KSH was found to be essential for
pathogenicity of M. tuberculosis (Hu et al. 2010) such
insights may allow structure-based design of inhibitors
against KSH activity to combat tuberculosis.
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Conclusions
Knowledge on KSH has increased substantially in
recent years, paving the way for biotechnological
exploitation of their catabolic potential. KSH is a key
enzyme in bacterial steroid catabolism and therefore
of strong physiological importance for a wide range of
sterol degrading bacteria. Mutant bacterial strains
devoid of KSH activity may convert relatively cheap
sterols into bioactive steroids that are pharmaceuti-
cally interesting. KSH enzymes also are essential for
pathogenicity of the notorious pathogen M. tubercu-
losis. Knowledge about the KSH catalysed reaction
may allow design of specific enzyme inhibitors to
combat tuberculosis. In summary, KSH enzymes are
highly interesting for many biotechnological and
medical applications. Further research will focus on
(a) the regulation of their expression in bacterial hosts,
against the background of other enzymes involved in
sterol conversion, aiming to increase efficiency of
metabolic conversions, (b) enzyme structural elements
determining substrate/product specificity, followed by
enzyme engineering to improve enzymatic
conversions.
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